Anti Obesity Prescription Drugs Market Scope And Analysis

  • Report Code : TIPRE00020942
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Anti-Obesity Prescription Drugs Market Scope and Growth 2031

Buy Now

Anti-Obesity Prescription Drugs Market Report Anti-Obesity Prescription Drugs Market Size and Share Anti-Obesity Prescription Drugs Market Scope and Analysis

Anti-Obesity Prescription Drugs Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 26%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Mechanism of Action
  • Peripherally Acting Drugs
  • Centrally Acting Drugs
By Drug Class
  • Bupropion and Naltrexone
  • Orlistat
  • Lorcaserin
  • Phentermine and Topiramate
  • Liraglutide
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • BRISTOL MYERS SQUIBB CO
  • TAKEDA PHARMACEUTICAL
  • EISAI COMPANY
  • GLAXOSMITHKLINE PLC
  • PFIZER INC
  • SHIONOGI USA INC
  • VIVUS INC
  • ZAFGEN INC
  • NORGINE BV